MedTrace Logo

A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

NCT02537483 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2015-09-14

No results posted yet for this study

Summary

The primary objective of this study is to compare the efficacy, safety, and tolerability of IDP-120 Gel to IDP-120 Component A, IDP-120 Component B, and IDP-120 Vehicle Gel in subjects with moderate to severe acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

DRUG

IDP-120 Gel

Investigational Product: IDP-120 Gel

DRUG

IDP-120 Component A

Comparator Product: IDP-120 Component A

DRUG

IDP-120 Component B

Comparator Product: IDP-120 Component B

DRUG

IDP-120 Vehicle Gel

Comparator Product: IDP-120 Vehicle Lotion

Sponsors & Collaborators

  • Valeant Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Anya Loncaric, MS · Valeant Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-09-30
Completion
2016-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02537483 on ClinicalTrials.gov